PPARG anticorps (N-Term)
Aperçu rapide pour PPARG anticorps (N-Term) (ABIN2339358)
Antigène
Voir toutes PPARG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-30, N-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- PPARG, NT (PPARG, NR1C3, Peroxisome proliferator-activated receptor gamma, Nuclear receptor subfamily 1 group C member 3)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 1-30 in the N-terminal region of human PPARG, UniProt Accession #P37231.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
-
Autre désignation
- PPARG
-
NCBI Accession
- NP_619725
-
UniProt
- P37231
-
Pathways
- Signalisation MAPK, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Antigène
-